Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Paragon Biosciences is a life science venture studio that creates, builds, and funds innovative biology-based companies. The firm focuses on addressing unmet medical needs through advanced technologies such as gene therapy, synthetic biology, and artificial intelligence. Paragon's unique model involves identifying breakthrough science and providing the necessary capital and operational expertise to launch and scale independent portfolio companies. Their ecosystem includes several notable subsidiaries and partners across various therapeutic areas including neurology, dermatology, and rare diseases. Founded by Jeff Aronin, the company has successfully launched multiple entities, including the publicly traded Harmony Biosciences. By maintaining a long-term investment horizon, Paragon aims to accelerate the path from discovery to commercialization for life-changing medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Paragon Biosci.